Clinical Trial Update: OpicApone Sleep dISorder [Phase 4]

View source ↗

Summary

Phase 4 trial of opicapone for sleep disturbances in Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• OpiCapone

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED